Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • NPPA fixes ceiling...

    NPPA fixes ceiling prices of 814 scheduled formulations

    Written by Ruby Khatun Khatun Published On 2017-07-03T14:34:02+05:30  |  Updated On 3 July 2017 2:34 PM IST

    New Delhi: New ceiling prices of 814 scheduled formulations became effective from today with drug pricing regulator NPPA fixing the cap in sync with the new GST regime.


    These formulations include medicines used for treatment of cancer, HIV, diabetes and infections among others.

    In a notification, National Pharmaceutical Pricing Authority (NPPA) said the fixation, revision of the prices of 814 scheduled formulations were done under Schedule-I under Drugs (Price Control) Amendment Order, 2016 under DPCO, 2013.

    Union Chemicals and Fertilisers Minister Ananth Kumar had said yesterday that NPPA will work out a mechanism ensuring patients do not pay more for drugs whose prices are expected to go up after the GST implementation.

    NPPA has already said that prices of around 78 per cent of 'actively used' drugs will remain unaffected after the rollout of the Goods and Services Tax (GST), which took effect today.

    "Price of drugs where partial increase is expected due to roll out of GST will not be passed on to consumers as NPPA is working out a mechanism in this regard," Kumar had told reporters.

    He had further stated NPPA is working out a mechanism "to subsume for partial increase of retail prices of some drugs".

    Kumar reiterated that "prices of life saving drugs and essential drugs rates will come down with reduction in GST rate".

    The regulator had earlier indicated that the prices of majority of essential drugs would increase by up to 2.29 per cent when the GST regime kicks in. The government has fixed GST rate of 12 per cent on most of the essential drugs as against the earlier tax incidence of around 9 per cent.

    To check out the list of fix prices schedule formulations click on the following links

    http://www.nppaindia.nic.in/ceiling/press30June17/so27042017e81-30-06-17_1.pdf

    http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_2.pdf

    http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_3.pdf

    http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_4.pdf


    http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_5.pdf

    http://www.nppaindia.nic.in/ceiling/press30June17/01so27042017e2-30-06-17_6.pdf
    814 scheduled formulationsAnanth Kumarcancerceiling pricesdiabetesDPCODrugs Price Control OrderGoods and Services TaxGSTHIVinfectionsmedicinesNational Pharmaceutical Pricing AuthorityNPPANPPA FIxes Ceiling Price
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok